{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:07:49Z","timestamp":1790460469298,"version":"4.1.0"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>People with diabetes have an increased risk of adverse events during the peri-colonoscopy period, including hypoglycemia, lactic acidosis, diabetic ketoacidosis and acute kidney injury. This is secondary to inadequate dietary modification, the bowel preparation and antihyperglycemic agent modification. With the availability of many new diabetes agents, endoscopists need updated guidance. This review of current literature provides a practical approach to antihyperglycemic agent modification in the context of colonoscopy preparation, as well as guidelines on dietary changes, the bowel preparation itself and glucose monitoring.<\/jats:p>","DOI":"10.1093\/jcag\/gwac035","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T11:48:17Z","timestamp":1672400897000},"page":"26-36","source":"Crossref","is-referenced-by-count":31,"title":["Preparing for Colonoscopy in People with Diabetes: A Review with Suggestions for Clinical Practice"],"prefix":"10.1093","volume":"6","author":[{"given":"Alexandra","family":"Chirila","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Toronto , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0264-2176","authenticated-orcid":false,"given":"Jill","family":"Tinmouth","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto , Toronto, Ontario , Canada"},{"name":"Sunnybrook Health Sciences Centre , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana J","family":"Halperin","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto , Toronto, Ontario , Canada"},{"name":"Sunnybrook Health Sciences Centre , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"issue":"5","key":"2023021017210603600_CIT0001","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1503\/cmaj.151125","article-title":"Recommendations on screening for colorectal cancer in primary care","volume":"188","author":"Canadian Task Force on Preventive Health Care","year":"2016","journal-title":"CMAJ"},{"issue":"23","key":"2023021017210603600_CIT0002","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1001\/jama.2016.5989","article-title":"Screening for colorectal cancer: US preventive services task force recommendation statement","volume":"315","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA - J Am Med Assoc"},{"issue":"5","key":"2023021017210603600_CIT0003","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jdiacomp.2013.04.010","article-title":"Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy","volume":"27","author":"Kanadiya","year":"2013","journal-title":"J Diabetes Complications"},{"issue":"1","key":"2023021017210603600_CIT0004","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1210\/endrev\/bnz014","article-title":"Review: Diabetes, obesity, and cancer-pathophysiology and clinical implications","volume":"41","author":"Lega","year":"2020","journal-title":"Endocr Rev"},{"issue":"11","key":"2023021017210603600_CIT0005","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/jnci\/95.11.831","article-title":"Risk of perforation after colonoscopy and sigmoidoscopy: A population-based study","volume":"95","author":"Gatto","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"2023021017210603600_CIT0006","article-title":"Table 13-10-0096-07 diabetes, by age group.","author":"Statistics Canada","year":"2022"},{"issue":"1","key":"2023021017210603600_CIT0007","first-page":"1","article-title":"New drugs for type 2 diabetes: Second-line therapy \u2014 Recommendations report.","volume":"4","author":"Canadian Agency for Drugs and Technologies in Health (CADTH)","year":"2017","journal-title":"Ther Rev Recomm"},{"issue":"5","key":"2023021017210603600_CIT0008","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/SGA.0b013e31822c3a24","article-title":"Diabetic colon preparation comparison study","volume":"34","author":"Hayes","year":"2011","journal-title":"Gastroenterol Nurs"},{"issue":"6","key":"2023021017210603600_CIT0009","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/2050640619846365","article-title":"Antihyperglycemic therapy during colonoscopy preparation: A review and suggestions for practical recommendations","volume":"7","author":"Hochberg","year":"2019","journal-title":"United Eur Gastroenterol J"},{"issue":"11","key":"2023021017210603600_CIT0010","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.2337\/dc20-1244","article-title":"Periprocedural euglycemic diabetic ketoacidosis associated with sodium\u2013 glucose cotransporter 2 inhibitor therapy during colonoscopy","volume":"43","author":"Meyer","year":"2020","journal-title":"Diabetes Care"},{"issue":"12","key":"2023021017210603600_CIT0011","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1111\/jgs.12585","article-title":"Metformin-associated lactic acidosis in an older adult after colonoscopy: An uncommon trigger for a rare complication","volume":"61","author":"Kwok","year":"2013","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"2023021017210603600_CIT0012","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.diabres.2013.12.055","article-title":"Acute renal failure and metformin-associated lactic acidosis following colonoscopy","volume":"105","author":"Hussain","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"2023021017210603600_CIT0013","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1155\/2013\/295412","article-title":"Open-access colonoscopy in Ontario: Associated factors and quality","volume":"27","author":"Hadlock","year":"2013","journal-title":"Can J Gastroenterol"},{"issue":"3","key":"2023021017210603600_CIT0014","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/pdi.913","article-title":"Endoscopy or colonoscopy guidelines for patients with diabetes. The development and audit of local pilot guidelines for patients with diabetes undergoing an endoscopy or colonoscopy as an out-patient","volume":"23","author":"Wamae","year":"2006","journal-title":"Pract Diabetes Int"},{"key":"2023021017210603600_CIT0015","volume-title":"Peri-Operative Diabetes Management Guidelines","author":"Australian Diabetes Society.","year":"2012"},{"issue":"4","key":"2023021017210603600_CIT0016","doi-asserted-by":"crossref","first-page":"e01957091","DOI":"10.1371\/journal.pone.0195709","article-title":"Predictive factors for missed adenoma on repeat colonoscopy in patients with suboptimal bowel preparation on initial colonoscopy: A KASID multicenter study","volume":"13","author":"Chang","year":"2018","journal-title":"PLoS One"},{"key":"2023021017210603600_CIT0017","volume-title":"Bowel Preparation Selection Best Practice Guidelines (BPSBPG)","author":"Quality Management Partnership Cancer Care Ontario.","year":"2021"},{"issue":"3","key":"2023021017210603600_CIT0018","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.gie.2015.09.045","article-title":"Low-residue versus clear liquid diet before colonoscopy: A meta-analysis of randomized, controlled trials","volume":"83","author":"Nguyen","year":"2016","journal-title":"Gastrointest Endosc"},{"issue":"11","key":"2023021017210603600_CIT0019","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1055\/s-0042-111320","article-title":"Efficacy of a multifactorial strategy for bowel preparation in diabetic patients undergoing colonoscopy: A randomized trial","volume":"48","author":"Alvarez-Gonzalez","year":"2016","journal-title":"Endoscopy"},{"issue":"2","key":"2023021017210603600_CIT0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1055\/s-0042-120322","article-title":"Bowel preparation in diabetic patients undergoing colonoscopy","volume":"49","author":"Panarese","year":"2017","journal-title":"Endoscopy"},{"issue":"7","key":"2023021017210603600_CIT0021","doi-asserted-by":"crossref","first-page":"e01822251","DOI":"10.1371\/journal.pone.0182225","article-title":"Scheduling rules for patients with diabetes mellitus that facilitate split-dosing improve the quality of bowel preparation for colonoscopy","volume":"12","author":"Hilsden","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"2023021017210603600_CIT0022","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1155\/2006\/915368","article-title":"Commonly used preparations for colonoscopy: Efficacy, tolerability and safety - A Canadian association of gastroenterology position paper","volume":"20","author":"Barkun","year":"2006","journal-title":"Can J Gastroenterol"},{"key":"2023021017210603600_CIT0023","volume-title":"Diabetic Nephropathy","author":"Varghese","year":"2022"},{"issue":"5","key":"2023021017210603600_CIT0024","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCG.0b013e3181662442","article-title":"Patient factors predictive of inadequate bowel preparation using polyethylene glycol: A prospective study in Korea","volume":"43","author":"Yong","year":"2009","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"2023021017210603600_CIT0025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MCG.0000000000000536","article-title":"Inadequate bowel cleansing efficacy of split-dose polyethylene glycol for colonoscopy in type 2 diabetic patients: A prospective and blinded study","volume":"51","author":"Kim","year":"2017","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"2023021017210603600_CIT0026","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1572-0241.2001.03610.x","article-title":"Decreased efficacy of polyethylene glycol lavage solution (Golytely) in the preparation of diabetic patients for outpatient colonoscopy: A prospective and blinded study","volume":"96","author":"Taylor","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"2023021017210603600_CIT0027","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cgh.2011.12.037","article-title":"A predictive model identifies patients most likely to have inadequate bowel preparation for colonoscopy","volume":"10","author":"Hassan","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"2023021017210603600_CIT0028","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s11938-018-0208-9","article-title":"Which patient-related factors determine optimal bowel preparation?","volume":"16","author":"Martel","year":"2018","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"12","key":"2023021017210603600_CIT0029","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00384-009-0757-4","article-title":"The effect of autonomous neuropathy on bowel preparation in type 2 diabetes mellitus","volume":"24","author":"Ozturk","year":"2009","journal-title":"Int J Colorectal Dis"},{"issue":"11","key":"2023021017210603600_CIT0030","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.3748\/wjg.v22.i11.3252","article-title":"Constipation, hard stools, fecal urgency, and incomplete evacuation, but not diarrhea is associated with diabetes and its related factors","volume":"22","author":"Ihana-Sugiyama","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2023021017210603600_CIT0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.212283","article-title":"A clinical review of GLP-1 receptor agonists: Efficacy and safety in diabetes and beyond","volume":"4","author":"Prasad-Reddy","year":"2015","journal-title":"Drugs Context"},{"issue":"7","key":"2023021017210603600_CIT0032","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4253\/wjge.v2.i7.263","article-title":"Lubiprostone used with \u00adpolyethylene glycol in diabetic patients enhances colonoscopy preparation quality","volume":"2","author":"Grigg","year":"2010","journal-title":"World J Gastrointest Endosc"},{"issue":"5","key":"2023021017210603600_CIT0033","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1210\/jc.2012-4127","article-title":"Hypoglycemia and diabetes: A report of a workgroup of the American diabetes association and the endocrine society","volume":"98","author":"Seaquist","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023021017210603600_CIT0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-021-01375-7","article-title":"Managing patients with insulin pumps and continuous glucose monitors in the hospital: To wear or not to wear","volume":"21","author":"Yeh","year":"2021","journal-title":"Curr Diab Rep"},{"issue":"11","key":"2023021017210603600_CIT0035","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/phar.1507","article-title":"GLP-1 receptor agonists for type 2 diabetes mellitus: Recent developments and emerging agents","volume":"34","author":"Trujillo","year":"2014","journal-title":"Pharmacotherapy"},{"key":"2023021017210603600_CIT0036","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fendo.2019.00389","article-title":"Clinical use of DPP-4 inhibitors","volume":"10","author":"Gallwitz","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2023021017210603600_CIT0037","doi-asserted-by":"crossref","first-page":"e29811","DOI":"10.1002\/dmrr.2981","article-title":"When metformin is not enough: Pros and cons of SGLT2 and DPP-4 inhibitors as a second line therapy","volume":"34","author":"Avogaro","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"issue":"January","key":"2023021017210603600_CIT0038","doi-asserted-by":"crossref","first-page":"100186","DOI":"10.1016\/j.obmed.2020.100186","article-title":"Metformin: A review of its therapeutic efficacy and adverse effects","volume":"17","author":"Shurrab","year":"2020","journal-title":"Obes Med"},{"key":"2023021017210603600_CIT0039","author":"Diabetes Canada.","year":"2020"},{"key":"2023021017210603600_CIT0040","first-page":"1","article-title":"Perioperative management of patients with diabetes","volume":"10","author":"Leung","year":"2017","journal-title":"Heal Serv Insights"},{"issue":"3","key":"2023021017210603600_CIT0041","doi-asserted-by":"crossref","first-page":"216","DOI":"10.21040\/eom\/2016.2.3.6","article-title":"Metabolic acidosis: Expected and fatal adverse effects of metformin and empagliflozin: A case series and literature review","volume":"2","author":"\u010cupi\u0107","year":"2016","journal-title":"Endocr Oncol Metab"},{"issue":"19","key":"2023021017210603600_CIT0042","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1001\/jama.2019.3805","article-title":"Metformin in 2019","volume":"321","author":"Flory","year":"2019","journal-title":"JAMA - J Am Med Assoc"},{"issue":"1","key":"2023021017210603600_CIT0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-017-0829-8","article-title":"Metformin: New preparations and nonglycemic benefits","volume":"17","author":"Fujita","year":"2017","journal-title":"Curr Diab Rep"},{"issue":"15","key":"2023021017210603600_CIT0044","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"2023021017210603600_CIT0045","first-page":"1","article-title":"Metformin in cancer prevention and therapy","volume":"2","author":"Kasznicki","year":"2014","journal-title":"Ann Transl Med"},{"issue":"7","key":"2023021017210603600_CIT0046","first-page":"658","article-title":"Metformin: Current knowledge","volume":"19","author":"Nasri","year":"2014","journal-title":"J Res Med Sci"},{"issue":"19","key":"2023021017210603600_CIT0047","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"10193","key":"2023021017210603600_CIT0048","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): A double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"3-4","key":"2023021017210603600_CIT0049","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1900\/RDS.2014.11.202","article-title":"Adverse effects of GLP-1 receptor agonists","volume":"11","author":"Filippatos","year":"2014","journal-title":"Rev Diabet Stud"},{"issue":"3","key":"2023021017210603600_CIT0050","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/anae.14180","article-title":"Peri-operative management of patients with type-2 diabetes mellitus undergoing non-cardiac surgery using liraglutide, glucose\u2013insulin\u2013potassium infusion or intravenous insulin bolus regimens: A randomised controlled trial","volume":"73","author":"Polderman","year":"2018","journal-title":"Anaesthesia"},{"issue":"5","key":"2023021017210603600_CIT0051","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/pdi.2110","article-title":"Evaluation of the effect of GLP-1 agonists on quality of bowel preparation for colonoscopy in patients with diabetes","volume":"34","author":"Sharma","year":"2017","journal-title":"Pract Diabetes"},{"issue":"3","key":"2023021017210603600_CIT0052","first-page":"195","article-title":"Cardiovascular effects of dipeptidyl peptidase-4 inhibitors","volume":"19","author":"Papagianni","year":"2015","journal-title":"Hippokratia"},{"issue":"1","key":"2023021017210603600_CIT0053","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1517\/14740338.2015.977863","article-title":"DPP-4 inhibitors: Focus on safety","volume":"14","author":"Tella","year":"2015","journal-title":"Expert Opin Drug Saf"},{"issue":"8","key":"2023021017210603600_CIT0054","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/anae.14251","article-title":"Sodium-glucose co-transporter type-2 inhibitors: Pharmacology and peri-operative considerations","volume":"73","author":"Milder","year":"2018","journal-title":"Anaesthesia"},{"issue":"7","key":"2023021017210603600_CIT0055","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"issue":"24","key":"2023021017210603600_CIT0056","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"issue":"22","key":"2023021017210603600_CIT0057","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"2023021017210603600_CIT0058","first-page":"S88","article-title":"Pharmacologic glycemic management of type 2 diabetes in adults","volume-title":"Can J Diabetes","author":"Lipscombe","year":"2018"},{"key":"2023021017210603600_CIT0059","first-page":"8639629","article-title":"A case of severe acute kidney injury exacerbated by canagliflozin in a patient with type 2 diabetes","volume":"2019","author":"Hassani-Ardakania","year":"2019","journal-title":"Case Rep Endocrinol"},{"issue":"12","key":"2023021017210603600_CIT0060","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/j.clinthera.2016.11.002","article-title":"SGLT2 Inhibitor\u2013associated diabetic ketoacidosis: Clinical review and recommendations for prevention and diagnosis","volume":"38","author":"Goldenberg","year":"2016","journal-title":"Clin Ther"},{"issue":"9","key":"2023021017210603600_CIT0061","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2337\/dc15-0843","article-title":"Euglycemic diabetic ketoacidosis: A potential complication of treatment with sodium-glucose cotransporter 2 inhibition","volume":"38","author":"Peters","year":"2015","journal-title":"Diabetes Care"},{"issue":"4","key":"2023021017210603600_CIT0062","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1517\/13543784.2016.1152260","article-title":"Investigational insulin secretagogues for type 2 diabetes","volume":"25","author":"Scheen","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"issue":"S1","key":"2023021017210603600_CIT0063","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1002\/dmrr.981","article-title":"Insulin therapy and quality of life. A review","volume":"25","author":"Pouwer","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"issue":"9","key":"2023021017210603600_CIT0064","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/dom.12485","article-title":"Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: Glycaemic control and hypoglycaemia with new insulin glargine 300 U\/ml versus glargine 100 U\/ml in people with type 2 diabetes","volume":"17","author":"Ritzel","year":"2015","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"2023021017210603600_CIT0065","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3329\/jemc.v4i2.19676","article-title":"Diabetic ketoacidosis: Pattern of precipitating causes","volume":"4","author":"Ahmed","year":"2014","journal-title":"J Enam Med Coll"},{"issue":"8","key":"2023021017210603600_CIT0066","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"11","key":"2023021017210603600_CIT0067","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s12630-015-0463-3","article-title":"A randomized controlled trial of light versus deep propofol sedation for elective outpatient colonoscopy: Recall, procedural conditions, and recovery","volume":"62","author":"Allen","year":"2015","journal-title":"Can J Anesth"}],"container-title":["Journal of the Canadian Association of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcag\/article-pdf\/6\/1\/26\/49157210\/gwac035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcag\/article-pdf\/6\/1\/26\/49157210\/gwac035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T17:23:24Z","timestamp":1676049804000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcag\/article\/6\/1\/26\/6965537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12,30]]},"published-print":{"date-parts":[[2023,2,10]]}},"URL":"https:\/\/doi.org\/10.1093\/jcag\/gwac035","relation":{},"ISSN":["2515-2084","2515-2092"],"issn-type":[{"value":"2515-2084","type":"print"},{"value":"2515-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,12,30]]}}}